OTSSP167, soluble in warmed DMSO and insoluble in water and ethanol, targets a kinase involved in cell cycle regulation and proliferation, offering therapeutic potential in cancer treatment by halting tumor growth. It targets MELK.
OTSSP167 can be employed to investigate its potent inhibition of MELK, particularly in breast cancer research.
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.